PR-FAMPRIDINE IMPROVES WALKING SPEED AND QUALITY OF LIFE IN MS

被引：0
|
作者：
Ewe, Renee [1 ]
Louissaint, Hannah [2 ]
Bull, Kate [2 ]
Allen, Joanne [2 ]
Farrell, Rachel [1 ,2 ]
机构：
[1] UCL, London, England
[2] UCLH, NHNN, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷
关键词：
D O I：
10.1136/jnnp-2017-ABN.155
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PO125
引用
下载
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [31] Walking, quality of life, and safety with prolonged-release fampridine treatment in clinical practice: Interim results of the liberate study
    Schmidt, S.
    Oschmann, P.
    Neau, J. P.
    Castelnovo, G.
    Wang, P.
    Barbato, L.
    Mahadavan, L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E21 - E21
  • [32] Fampridine-SR: A potassium-channel blocker for the improvement of walking ability in patients with MS
    Feret, Brett
    FORMULARY, 2009, 44 (10) : 293 - +
  • [33] The impact of fampridine on fatigue, cognitive function, mood and quality of life
    Baruca, M.
    Pelicon, K.
    Pasic, K.
    Ledinek, A. Horvat
    Noc, A. Pirecnik
    Rot, U.
    Jakob, G. Brecl
    Jazbec, S. Sega
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 664 - 665
  • [34] Could fampridine change gait kinematics to improve walking speed in primary progressive multiple sclerosis?
    Gonzalez-Suarez, I.
    Gomez-Andres, D.
    Montero-Atalaya, A.
    Pulido-Valdeolivas, I.
    Rodriguez-Andonaegui, I.
    Martin-Gonzalo, J. A.
    Orviz-Garcia, A.
    Lopez de Velasco, V.
    Rausell, E.
    Oreja-Guevara, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 199 - 200
  • [35] Quality of life and SR-fampridine in multiple sclerosis patients
    Derache, N.
    Chevanne, D.
    Creveuil, C.
    Defer, G. -L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 780 - 780
  • [36] Fampridine effects on upper limbs motor function and quality of life
    Lagorio, A. N.
    Costa Arpin, E.
    Puente Hernandez, M.
    Prieto Gonzalez, J. M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 417 - 417
  • [37] QUALITY OF LIFE AMONG PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH PROLONGED-RELEASE FAMPRIDINE 10 MG TABLETS FOR WALKING IMPAIRMENT
    Liu, Y.
    McNeill, M.
    Lee, A.
    Zhong, J.
    Mehta, L. R.
    VALUE IN HEALTH, 2014, 17 (07) : A401 - A402
  • [38] Multiple sclerosis patients with severe walking disability have clinically meaningful improvements in walking speed with prolonged-release fampridine
    Hartung, H. P.
    Goodman, A.
    Putzki, N.
    JOURNAL OF NEUROLOGY, 2011, 258 : 260 - 261
  • [39] Improved Walking Speed in Prolonged-Release Fampridine Timed Walk Responders May Translate to Improvements in Functional Walking Ability
    van Asch, Paul
    Goodman, Andrew
    NEUROLOGY, 2013, 80
  • [40] Ground-based walking training improves quality of life and exercise capacity in COPD
    Wootton, Sally L.
    Ng, L. W. Cindy
    McKeough, Zoe J.
    Jenkins, Sue
    Hill, Kylie
    Eastwood, Peter R.
    Hillman, David R.
    Cecins, Nola
    Spencer, Lissa M.
    Jenkins, Christine
    Alison, Jennifer A.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) : 885 - 894
12345